R1 RCM (NASDAQ:RCM) Downgraded by TheStreet to “D+”

TheStreet downgraded shares of R1 RCM (NASDAQ:RCMGet Rating) from a c- rating to a d+ rating in a research report released on Monday, TheStreetRatingsTable reports.

Several other equities analysts also recently issued reports on RCM. KeyCorp dropped their price target on shares of R1 RCM from $30.00 to $10.00 and set an overweight rating for the company in a research note on Wednesday, November 9th. Cowen dropped their price target on shares of R1 RCM from $34.00 to $25.00 in a research note on Monday, November 14th. Cowen dropped their price target on shares of R1 RCM from $34.00 to $25.00 and set an outperform rating for the company in a research note on Monday, November 14th. Royal Bank of Canada dropped their price target on shares of R1 RCM from $35.00 to $12.00 and set an outperform rating for the company in a research note on Wednesday, November 9th. Finally, Barclays decreased their price objective on shares of R1 RCM to $12.00 in a research report on Tuesday, November 15th. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat, R1 RCM presently has an average rating of Moderate Buy and a consensus target price of $18.67.

R1 RCM Price Performance

Shares of NASDAQ:RCM opened at $7.97 on Monday. The company has a market cap of $3.32 billion, a price-to-earnings ratio of 132.83 and a beta of 0.94. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.56 and a quick ratio of 1.54. The firm has a 50 day simple moving average of $15.31 and a 200 day simple moving average of $19.98. R1 RCM has a one year low of $6.71 and a one year high of $27.86.

Insider Transactions at R1 RCM

In other news, Director Achi Series Lllp Tcp-Asc sold 15,000,000 shares of R1 RCM stock in a transaction dated Tuesday, September 13th. The shares were sold at an average price of $20.43, for a total value of $306,450,000.00. Following the completion of the transaction, the director now owns 164,754,055 shares in the company, valued at $3,365,925,343.65. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 59.40% of the company’s stock.

Hedge Funds Weigh In On R1 RCM

Several hedge funds have recently bought and sold shares of the company. Teachers Retirement System of The State of Kentucky purchased a new position in R1 RCM during the third quarter valued at approximately $3,012,000. California State Teachers Retirement System grew its stake in R1 RCM by 2.2% during the third quarter. California State Teachers Retirement System now owns 179,995 shares of the healthcare provider’s stock valued at $3,335,000 after acquiring an additional 3,826 shares in the last quarter. M&T Bank Corp grew its stake in R1 RCM by 14.0% during the third quarter. M&T Bank Corp now owns 95,996 shares of the healthcare provider’s stock valued at $1,778,000 after acquiring an additional 11,763 shares in the last quarter. Retirement Systems of Alabama grew its stake in R1 RCM by 1.8% in the 3rd quarter. Retirement Systems of Alabama now owns 179,755 shares of the healthcare provider’s stock worth $3,331,000 after buying an additional 3,140 shares in the last quarter. Finally, Balyasny Asset Management LLC purchased a new position in R1 RCM in the 3rd quarter worth approximately $1,283,000. Hedge funds and other institutional investors own 49.86% of the company’s stock.

About R1 RCM

(Get Rating)

R1 RCM Inc provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers.

Read More

Analyst Recommendations for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.